Kel~52, All your recent posts are getting more "Thumb Down" ... than my posts ...
Looks like the forum is finally seeing clearer lol ...
I completely agree with your take ... thank you and good luck to you.
But then, what scientist doesn't recognize value when seen? Put another way, what scientist bought $6-10 but couldn't backup the truck to buy all possible at $2, if all is well?
Reminded me of PLUG too. Nothing but world-class customers - BMW, Boeing, Home Depot, WM, Kroger. Promises after promises. Acquisitions. Fancy presentations after presentations. But then, nothing but misses Q after Q. Lower and Lower PPS. Nothing but PAIN ....
"JPJ & small consortium finance $25,000,000 worth of convertible providing all the copanies needs well into profitability"
its~, this is nothing but WISHFUL thinking!
"Stock could run maybe even back to double digits."
Seriously? This is about to break $2 -- heading south daily. Give me $3-5 before feel-good double-digits.
I like your take, details and optimism .... however, we have to be objective here:
1. Refi will be handled by JPJ and other interested insiders over the next few quarters .
-- Where was PPJ when he/everyone got diluted 7-8 months ago?
2. Revenue will soon start to come in as Big Pharma becomes dependent on CGIX testing products.
-- "Will soon"? How soon? After they ran out of money and PPS is in PENNY zone?
Reminded me of MCP (Molycorp): (Not same sector, so not Apples-to-Apples comparison)
1. World-class REE facility
2. Outside of China - largest REE
3. Dropped from 60s to 10s
4 . Molibdenos y Metales S.A. (Molymet) pumped in 100 of millions of $ (100s of millions)
5. Yet, dilution after dilution
6. Management's Promises after promises of profitability - Fancy Presentations and Videos
7. MCP can NEVER go under because USA military will NOT allow
8. Congress will NOT allow
9. Drip, drip, drip 10, 7, 5, 3, 2 0!
10. MCP went BK a year or two ago.
Just saying .... time is ticking, enough BS! If PPJ and insiders can REFI, why not YESTERDAY or NOW?
Also, WHY INSIDERS are NOT BUYING BOATLOADS at this level if it'll be a GREAT investment?
Pathetic! "The Most Comprehensive & Clinically Actionable" is also rejected by the street!
Broken stock, DAMAGED GOOD - ZERO respect!
"I'm a little short on time today but I've read Tomdakings article n reaction by some such as netex."
Since you mentioned "netex" - Net is hurting and he can tell you quarter after quarter, this P0$/P0J records lower and lower PPS in face of presentations after presentations. Plus, no insider buying (not PPJ and not 1K by spineless executives). Now, that st!nks! That's Net's position, since you asked for it.
Who priced the IPO of this at $10 anyway?
Here we go:
Published May 12th, 2016 by Thomas Gaffney
Seriously thinking about it TomD~, this is beyond stink at this point ... too much pain here ...
If they are "bunch of scientists and academic types not business or financial types." - Why don't the F! hire FINANCIAL types?
Are they s2up!d or what?!
I completely agree with you - this thing could probably go BK the way this is going. This was captured in this January post by dwoods4q:
"Reply to news?? by tomdaking5 •Jan 5, 2016 1:21 PM
dwoods4q • Jan 5, 2016 2:34 PM Flag
0users liked this postsusers disliked this posts0
haven't they ALWAYS been quiet, they are a bunch of scientists and academic types not business or financial types."
That's what markets says, not me!
Markets not buying pre-ER hypes and delusions ... gets rewarded with -11% haircut!
Pathetic at best! :-(
These guys need to be buying. If they are not buying what they are selling - how are others supposed to buy it?
I presume you will be publishing article on this (burn rate and need to raise cash = dilution) sooner than later ...
Yeah, very odd for me today too ... Yahoo is sowing 15% upside and my AC is showing same ... I must be dreaming! Oh well, about time this shines, if only into ER!
Ladies, we may draw get some relief here ... after 7 months of total madness!
They had better with recent assertive headline like:
"Significantly Expands Marketshare In Immuno-Oncology Focused Clinical Trials With 12 Active Clinical Trials In Progress With Leading Biotech and Pharma Companies"
dkb~, the "setback" was not OPK's setback per se but the facility they are using:
OPKO Health Says FDA Accepts Resubmission Of NDA For Its RAYALDEE By R. Chandrasekaran April 27, 2016 2:10 PM
"OPKO indicated it resubmitted the NDA after the receipt of a complete response letter (CRL) from the FDA on March 29, 2016, in which the regulator indicated the NDA could not be approved due to deficiencies observed during a facility inspection of OPKO's third party manufacturer.
The company said the observations were not specific to RAYALDEE manufacturing, and the CRL did not point out any safety, efficacy or labeling issues in respect of RAYALDEE, nor did it request any additional studies to be conducted before the FDA approval. The drug firm said that a six month review period was assigned for the resubmitted NDA, and that the new Prescription Drug User Fee Act (PDUFA) date would be October 22."
Note: OPK is up 4% today - wishes I have some but all by funds are tied up in this :-(
InPlay Headline: 7:32 am (05/09/2016) Opko Health enters into a collaboration and license agreement for RAYALDEE w/ Vifor Fresenius (FMS) Medical Care Renal Pharma; to receive up to $282 mln in upfront and milestone payments